Michael J. Wick
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Ear and Head Tumors
- HER2/EGFR in Cancer Research
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 18
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 5
-
- PI3K/AKT/mTOR signaling in cancer 10
- Protein Kinase Regulation and GTPase Signaling 7
- Protein Degradation and Inhibitors 3
- Co-authors
- Lily Dong (7 shared papers)David Sidransky (4 shared papers)Manuel M. Hidalgo (3 shared papers)Elizabeth M. Bruckheimer (2 shared papers)Feng Liu (4 shared papers)Amita Patnaik (2 shared papers)Ignacio Garrido‐Laguna (1 shared paper)Elizabeth De Oliveira (1 shared paper)
- Journals
- Clinical Cancer Research (5 papers)Molecular Cancer Therapeutics (4 papers)Journal of Biological Chemistry (4 papers)Journal of Medicinal Chemistry (4 papers)Cancer Research (3 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Michael J. Wick
60 papers receiving 3.0k citations
Michael J. Wick's Hit Papers
Peers
Comparison fields: 5 of 139
- Oncology 1.1k
- Cancer Research 374
- Molecular Biology 1.4k
- Pathology and Forensic Medicine 244
- Biotechnology 118
Countries citing papers authored by Michael J. Wick
This map shows the geographic impact of Michael J. Wick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Wick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Wick more than expected).
Fields of papers citing papers by Michael J. Wick
This network shows the impact of papers produced by Michael J. Wick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Wick. The network helps show where Michael J. Wick may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael J. Wick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer Hit paper breakdown → | 2012 | 383 |
| 2 | 2011 | 350 | |
| 3 | 2016 | 246 | |
| 4 | 2017 | 200 | |
| 5 | 2017 | 193 | |
| 6 | 2000 | 115 | |
| 7 | 2015 | 105 | |
| 8 | 2018 | 95 | |
| 9 | 2000 | 90 | |
| 10 | 2017 | 79 | |
| 11 | 2018 | 78 | |
| 12 | 2011 | 76 | |
| 13 | 2003 | 70 | |
| 14 | 2012 | 64 | |
| 15 | 2018 | 61 | |
| 16 | 2018 | 60 | |
| 17 | 2003 | 59 | |
| 18 | 2008 | 52 | |
| 19 | 2001 | 51 | |
| 20 | 1981 | 50 |
About Michael J. Wick
Michael J. Wick is a scholar working on Oncology, Molecular Biology, Cancer Research, Genetics and Oral Surgery, having authored 61 papers that have together received 3.1k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (10 papers), Salivary Gland Tumors Diagnosis and Treatment (8 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (5 papers), Protein Degradation and Inhibitors (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (374 citations), Molecular Biology (1.4k citations), Pathology and Forensic Medicine (244 citations) and Biotechnology (118 citations). Michael J. Wick has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Lily Dong, David Sidransky, Manuel M. Hidalgo, Elizabeth M. Bruckheimer, Feng Liu, Amita Patnaik, Ignacio Garrido‐Laguna, Elizabeth De Oliveira, Steven J. Strawn and James A. Martell. Their work appears in journals such as Clinical Cancer Research, Molecular Cancer Therapeutics, Journal of Biological Chemistry, Journal of Medicinal Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.